These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2249882)

  • 21. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.
    Akram A; Inman RD
    Eur J Immunol; 2013 Dec; 43(12):3254-67. PubMed ID: 24113999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of xenoantigenicity of HLA class I molecules by a complete series of human-mouse hybrid genes.
    Tanabe M; Takiguchi M; Yamamoto J; Hayashi H; Kano K
    Transplantation; 1989 Jul; 48(1):135-40. PubMed ID: 2787554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of human leucocyte antigen class I transgenic mice to investigate human immune function.
    Faulkner L; Borysiewicz LK; Man S
    J Immunol Methods; 1998 Dec; 221(1-2):1-16. PubMed ID: 9894893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity.
    Schneider Z; Cervenak J; Baranyi M; Papp K; Prechl J; László G; Erdei A; Kacskovics I
    Immunol Lett; 2011 Jun; 137(1-2):62-9. PubMed ID: 21338624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
    Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
    Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses against Abeta1-42 in HLA class II transgenic mice: implications for Abeta1-42 immune-mediated therapies.
    Das P; Chapoval S; Howard V; David CS; Golde TE
    Neurobiol Aging; 2003 Nov; 24(7):969-76. PubMed ID: 12928057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope analysis of an HLA-B27-derived synthetic peptide: a possible approach to analyzing HLA class I antigens.
    Zhao YP; Shi BJ; Deng HK; Yu DT; Hamachi M; Hamachi T; Zhao DF; Tang SR; Tsang JC; Park MS
    Clin Exp Rheumatol; 1991; 9(3):235-9. PubMed ID: 1715248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA typing with monoclonal antibodies: evaluation of 356 HLA monoclonal antibodies including 181 studied during the 10th International Histocompatibility Workshop.
    Colombani J; Lepage V; Raffoux C; Colombani M
    Tissue Antigens; 1989 Aug; 34(2):97-110. PubMed ID: 2609328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
    Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
    J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus.
    Harada N; Fukaya S; Wada H; Goto R; Osada T; Gomori A; Ikizawa K; Sakuragi M; Oda N
    J Immunol; 2017 Jan; 198(1):516-527. PubMed ID: 27881704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of an HLA-DR alpha-specific monoclonal antibody using L-cell transfectants expressing human and mouse class II major histocompatibility dimers.
    Palmer D; Kevany M; Mackworth-Young C; Batchelor R; Lombardi G; Lechler R
    Immunogenetics; 1991; 33(1):12-7. PubMed ID: 1995473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of xenogeneic neonatal tolerance to transgenic human leukocyte antigen class I grafts.
    Borenstein SH; Tao KS; Mendicino M; Hu N; West LJ; Chamberlain JW
    Transplantation; 2004 Sep; 78(6):844-52. PubMed ID: 15385803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to HLA-DP-transfected mouse L cells.
    Heyes J; Austin P; Bodmer J; Bodmer W; Madrigal A; Mazzilli MC; Trowsdale J
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3417-21. PubMed ID: 3517859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
    Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
    Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody.
    Bensussan A; Mansur IG; Mallet V; Rodriguez AM; Girr M; Weiss EH; Brem G; Boumsell L; Gluckman E; Dausset J
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10292-6. PubMed ID: 7479770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a monoclonal antibody recognizing a polymorphic epitope mainly on HLA-DPw2 and DPw4 molecules.
    Viken HD; Gaudernack G; Thorsby E
    Tissue Antigens; 1989 Oct; 34(4):250-9. PubMed ID: 2482551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.